SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

CTSO

Cytosorbents Corporation
NASDAQHealth Care

Latest close: 4.06 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 23, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 15, 2026Reported purchase · Form 4Alan D. Sobel · $11.6KOpen the filing ↗
  3. Sep 15, 2026Reported purchase · Form 4Alan D. Sobel · $3.0KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record90914 flagged findings
Reported transactions (Form 4)80since Dec 13, 2023 · and 2 other holdings
Corporate events (8-K)30since Jul 27, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-09-08reverse splitfreshOpen filing ↗
    “…extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a)…”
    +1 more passage from the same document
    • “…for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ Item…”
  • 2026-08-14reverse splitfreshOpen filing ↗
    “…(ii) the compensation of the Company’s named executive officers, disclosed pursuant to Item 402 of Regulation S-K, was approved, on a…”
    +1 more passage from the same document
    • “…of the Company’s named executive officers, disclosed pursuant to Item 402 of Regulation S-K; 3. The ratification of the appointment…”
  • 2026-08-06share offering or dilution eventfreshOpen filing ↗
    “…the closing of the Company’s Loan and Security Agreement with Avenue Capital Group (see Note 6. “Long-Term Debt”) and these warrants…”
    +1 more passage from the same document
    • “…its previously announced rights offering (the “Rights Offering”), raising aggregate gross proceeds of $ 6.25 million ($ 5.4 million…”
  • 2026-08-06listing compliance noticefreshOpen filing ↗
    “…$35 million minimum required under Nasdaq Listing Rule 5550(b)(2), the MVLS Requirement, and under Nasdaq Listing Rule…”
    +1 more passage from the same document
    • “…we have until December 28, 2026, to regain such compliance. As of the date of this report, we have not regained compliance with…”
  • 2026-08-06reverse splitfreshOpen filing ↗
    “…Company with 180 calendar days, or until December 28, 2026, to regain compliance with the MVLS Requirement. Management’s plans with…”
    +1 more passage from the same document
    • “…compliance periods, or that we will otherwise satisfy the Nasdaq continued listing standards. We continue to actively monitor…”
  • 2026-04-15share offering or dilution eventrecentOpen filing ↗
    “…19,534 shares of Common Stock, 2,631 warrants, and 148,425 shares of Common Stock issuable pursuant to stock options currently…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Jul 6, 2026).

Deadline: Dec 26, 2026

  • market value of listed securities · Nasdaq, rule 5550(b)(2) · notice of Jun 29, 2026 · pending · deadline Dec 26, 2026 (text and rule agree)

Open the 8-K at the SEC

Reverse splits in 5 years

1 reverse split in 5 years (1:20 on Sep 8, 2026) · 1:20 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 909)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 23, 268-K ↗Current report · Communication to the market · Other events
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Sep 8, 268-K ↗Current report · Bylaws or fiscal year change
  • Aug 14, 268-K ↗Current report · Shareholder vote results
  • Aug 7, 268-K ↗Current report · Communication to the market
  • Aug 6, 268-K ↗Current report · Results
  • Aug 6, 2610-Q ↗Quarterly report
  • Jul 6, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Jun 25, 26DEFA14A ↗Shareholder meeting and votes
  • Jun 25, 26DEF 14A ↗Shareholder meeting and votes
  • Jun 25, 268-K ↗Current report · Communication to the market
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Jun 11, 26PRE 14A ↗Shareholder meeting and votes
  • May 13, 2610-Q ↗Quarterly report
  • May 13, 268-K ↗Current report · Results
  • Apr 15, 2610-K/A ↗Annual report · amendment
  • Apr 2, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Mar 30, 2610-K ↗Annual report
  • Mar 25, 268-K ↗Current report · Results · Communication to the market
  • Feb 13, 26SCHEDULE 13G/A ↗Passive stake · AVENIR CORP · 8.3% · event on Dec 31, 25 · amendment
  • Nov 20, 25Form 4 ↗Insider transaction

909 filings on record, the oldest from Dec 1, 04.

Listing the 25 most recent filings of the 909 on record.

8-Ks, explained

Stress6Structure54Governance53
  • Stress3 listing notices2025 – 2026show all 3hide
  • Aug 7, 25StructureCompleted an acquisition or disposal+1 more in the same filing8-K 2.01 ↗
  • Mar 31, 25StressPast accounts declared unreliable and being restated8-K 4.02 ↗
  • Aug 20, 24StructureEntered a material agreement8-K 1.01 ↗
  • Aug 16, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 5, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 22, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 3, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jan 17, 24StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Dec 11, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Sep 19, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Sep 1, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗

12 older filings not shown · The record reaches back to Jan 13, 06.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • AVENIR CORP8.3%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Thomas A. Satterfield, Jr.6.6%Jan 13, 25SCHEDULE 13G ↗
  • Avenue Capital Management II, L.P.5.7%Jun 26, 24SCHEDULE 13G ↗8 co-filers on this document — the figure is the largest single stake, not their sum.
  • Skylands Capital, LLC4.8%Mar 31, 25SCHEDULE 13G ↗1 earlier filing
  • The Vanguard Group3.1%Mar 31, 25SCHEDULE 13G/A ↗1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 15, 26Buy$12KAlan D. Sobel↗
  • Sep 15, 26Buy$3KAlan D. Sobel↗
  • Sep 15, 26Buy$601Alan D. Sobel↗
  • Sep 15, 26Buy$23KPhillip P. ChanChief Executive Officer↗
  • Sep 14, 26Buy$11KVincent CapponiPresident and COO↗
  • Sep 14, 26Buy$2KVincent CapponiPresident and COO↗
  • Sep 4, 26Buy$70KPhillip P. ChanChief Executive Officer↗
  • Jun 15, 26Buy$4KPhillip P. ChanChief Executive Officer↗
  • Jun 15, 26Buy$44KPETER J MARIANIChief Financial Officer↗
  • Jun 12, 26Buy$100KPhillip P. ChanChief Executive Officer↗
  • Dec 13, 24Buy$19KPETER J MARIANIChief Financial Officer↗
  • Dec 12, 24Buy$18KPETER J MARIANIChief Financial Officer↗

There are 5 more transactions in this stretch.

Stock compensation, tax and giftsshow the 23 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Nov 18, 25Compensation$64KPhillip P. ChanChief Executive Officer↗
  • Aug 8, 25Compensationamount n/aEfthymios DeliargyrisChief Medical Officer↗
  • Aug 8, 25Compensationamount n/aVincent CapponiPresident and COO↗
  • Aug 8, 25Compensationamount n/aPETER J MARIANIChief Financial Officer↗
  • Aug 8, 25Compensationamount n/aPhillip P. ChanChief Executive Officer↗
  • Feb 24, 25Other$25KAlan D. Sobel↗
  • Feb 24, 25Other$39KPhillip P. ChanChief Executive Officer↗
  • Feb 24, 25Other$37KPETER J MARIANIChief Financial Officer↗
  • Feb 24, 25Other$14KVincent CapponiPresident and COO↗
  • Feb 24, 25Other$11KMICHAEL G. BATOR↗
  • Jan 17, 25Other$33KPETER J MARIANIChief Financial Officer↗
  • Jan 17, 25Other$91KPhillip P. ChanChief Executive Officer↗
  • Jan 17, 25Other$22KAlan D. Sobel↗
  • Jan 17, 25Other$16KEfthymios DeliargyrisChief Medical Officer↗
  • Jan 17, 25Other$32KVincent CapponiPresident and COO↗
  • Jan 17, 25Other$16KMICHAEL G. BATOR↗
  • Aug 14, 24Compensationamount n/aPETER J MARIANIChief Financial Officer↗
  • Aug 14, 24Compensationamount n/aPETER J MARIANIChief Financial Officer↗
  • Aug 14, 24Compensationamount n/aPETER J MARIANIChief Financial Officer↗
  • Apr 2, 24Compensationamount n/aPhillip P. ChanChief Executive Officer↗
  • Apr 2, 24Compensationamount n/aVincent CapponiPresident and COO↗
  • Apr 2, 24Compensationamount n/aKATHLEEN P. BLOCHChief Financial Officer↗
  • Apr 2, 24Compensationamount n/aEfthymios DeliargyrisChief Medical Officer↗

The full record holds 62 transactions and goes back to Feb 6, 23.

Its sector and its market

Cytosorbents Corporation among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Cytosorbents Corporation, the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Cytosorbents Corporation in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
909 documents on file, from Dec 1, 2004 to Sep 23, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Cytosorbents Corporation (CTSO): stock price history, insider trades and SEC filings — HornScout